Log In

What Should Diagnostic Labs Look for in a Patient Engagement Platform?
A laboratory professional in a white coat and blue gloves holds a sample tube beside a microscope.

Diagnostic laboratories are increasingly exploring digital tools to improve patient engagement before appointments, sample collection and follow-up. For lab owners, operations leads and digital services managers, the opportunity is a more accessible, organized patient journey without adding complexity to existing workflows.

White-label solutions add another option: delivering digital services under a laboratory’s own brand while testing whether the technology fits its operations.

What can digital engagement tools help patients prepare before a lab visit?

Before testing, patients may need help organizing symptoms, noting when they noticed a change and working out what to ask a healthcare professional.

Digital intake forms, education portals and guided questionnaires can help structure this information. General content may explain common procedures, but preparation instructions should always come from the laboratory’s approved guidance for the specific test.

The goal is preparation, not self-diagnosis. A digital tool should not decide which tests a patient needs; that decision rests with the clinician.

What is the difference between a white-label service and a system integration?

A white-label service allows a laboratory to present a digital product using its own name, logo, colours and branding. The technology may still be hosted and operated by a third party.

A system integration connects software systems so information can move between them, for example linking an engagement tool to a laboratory information system (LIS), booking platform or patient portal.

A service can be white-labelled without being integrated. Before signing, clarify branding rights, data flows, hosting, supported integrations and implementation costs.

What commercial approaches can labs compare?

The examples below illustrate three different approaches. Each summary reflects vendor-described features from the vendor’s own website, not independently verified performance or outcomes, and inclusion is not an endorsement.

  • Results delivery under the lab’s brand. Advant Health describes a white-label results portal with HL7 connectivity. A lab can use this to release results to patients and referring providers through a branded portal connected to existing systems.
  • Branded reports and patient portals. ClinikPe describes branded reports and patient portals, with advanced branding options depending on plan. A lab may use this to present reports and patient access under its own identity, after confirming what its plan includes.
  • Custom development and integration. FRESME’s digital health page describes a platform development and integration offering, with scope agreed per project. A lab might consider this route for a tailored, integrated service. The available modules, integrations and implementation requirements depend on the agreed project scope.

Verify functionality, regulatory suitability, security, pricing and availability directly with each vendor.

Where could a patient-controlled FaceEcho report fit?

Camera-based engagement is a separate, emerging category. FaceEcho could support preparation before a clinician consultation by helping patients organize concerns and questions. Labs interested in connecting FaceEcho with their systems can contact the team to discuss integration requirements and development.

Illustrative workflow

  1. A patient completes a guided scan and answers relevant questions in FaceEcho.
  2. The patient reviews the report, which organizes visible observations and the context they provided.
  3. The patient downloads the report as a PDF and decides whether to share it with a clinician.
  4. The clinician considers the information alongside their own assessment and decides whether further assessment or testing is appropriate.
  5. If the clinician orders a test, the patient books through the lab’s usual channels and follows its approved preparation instructions for that test.

FaceEcho supports guided scans, relevant questions, report review, PDF download and patient-controlled manual sharing. White-label arrangements are available; specific scope and implementation must be agreed with FaceEcho. Automated report delivery, booking connections and LIS integration are not currently available. The scan does not recommend tests or direct patients to testing; clinical decisions stay with the clinician.

Lab engagement platforms can also support patients after testing, through patient access to released results, lab-approved explanations and a way to note questions for clinician follow-up. These are general capabilities of the category, not existing FaceEcho functions. Preparation for any further test should still follow the lab’s approved instructions for that specific test.

What should a lab verify before agreeing to a pilot?

A pilot should begin with a clearly defined operational objective and agreed evaluation criteria. Key measures may include:

  • Participation: The number and proportion of eligible patients who choose to use the service.
  • Completion: The proportion of participants who successfully complete the engagement experience.
  • Report usefulness: The extent to which patients and clinicians find the information clear, relevant and useful.
  • Accessibility: The ease of navigating the experience across different devices and levels of digital literacy.
  • Staff workload: The additional administrative, operational and support resources required.
  • Privacy: The types of information collected, access permissions, sharing practices, data retention and processes for exercising applicable privacy rights.
  • Technical feasibility: The capabilities currently available, compatibility with existing systems and requirements for further development.
  • Cost and scalability: The implementation costs, ongoing maintenance requirements and operational resources needed to support expansion.

Agree on success criteria, duration, staff responsibilities and review procedures before launch. Participation or completion alone does not demonstrate clinical benefit; claims about accuracy, outcomes or test selection would need evidence suited to those claims.

Frequently asked questions

1. Does a digital engagement tool replace a clinician’s assessment?

No. It supports preparation and communication but does not replace clinical judgment.

2. Does white-labelling mean the platform connects to our LIS?

No. Branding and integration are separate and must be confirmed contractually and technically.

3. Can patients automatically send FaceEcho reports to our laboratory?

Not currently. Patients download their PDF report and choose whether to share it themselves. Automated report delivery, booking connections and LIS integration are not currently available.

4. How long should a pilot run?

There is no universal timeframe. Agree on a period long enough to assess participation, completion, usability and operational impact. Considering a pilot? Visit FaceEcho for Labs to discuss whether a defined pilot could fit your laboratory.

Sources